REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Insights & Implications in Gerontology: Agitation in Alzheimer's Disease by GSAStrategicAlliances - Issuu

Psychiatry Alzheimer's Diseasearticles page [1]

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Lundbeck, Otsuka's Rexulti wins FDA nod for Alzheimer's agitation

SLU Researcher Finds Help for Alzheimer's-Associated Agitation with New FDA-Approved Treatment : SLU

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

This Month in Psychopharmacology

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Otsuka and Lundbeck Issue Statement on REXULTI for Alzheimer's